Back to search

Article

PGK1, a promising biomarker and therapeutic target for patients with acute myeloid leukemia who are susceptible to disease relapse

2020-07-14

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Glycolysis, a multi-step enzymatic reaction, is considered to be the root of cancer development and progression. The aim of this study is to figure out the glycolytic enzyme, phosphoglycerate kinase 1 (PGK1) whether participate in the progression of acute myeloid leukemia (AML) and its possible mechanisms. <bold>Methods</bold>: Four datasets (GSE106096, GSE75086...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a118cff0-8daa-5403-9255-62f354d6e2c4
DOI
10.21203/rs.3.rs-41160/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PGK1, a promising biomarker and therapeutic target for patients with acute myeloid leukemia who are susceptible to disease relapseDOI 10.21203/rs.3.rs-41160/v1
Select a neighboring publication to make it the new centre.